Diffuse Non Hodgkin S Lymphoma Large Cell — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for diffuse non hodgkin s lymphoma large cell. 19 active patents protecting 2 drugs from 1+ originators. First major cliff: 2027. Daily refresh.

2
Approved drugs
19
Active US patents
61/100
Avg vulnerability
—
Annual revenue covered

Originators in Diffuse Non Hodgkin S Lymphoma Large Cell

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Schering) 19 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating diffuse non hodgkin s lymphoma large cell. Each bar = one year. Y-axis scaled to peak year (5 patents).

5
27
2
28
2
30
1
32
3
34
1
36
3
37
1
39
1
41

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Decadron
dexamethasone
 Generic (originally Merck) 15 46 — 2027-12-19
Deltasone
prednisone
 Generic (originally Schering) 4 76 — 2027-08-03

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8168218 Deltasone method of use 80 2028-01-07
9504699 Deltasone method of use 75 2027-08-03
9504699 Deltasone method of use 75 2027-08-03
9504699 Deltasone method of use 75 2027-08-03
8101582 Decadron method of use 63 2027-12-19
7795316 Decadron method of use 63 2028-08-03
12150896 Decadron method of use 58 2036-10-07
12144889 Decadron method of use 58 2041-04-26
11458041 Decadron method of use 53 2037-11-16
11304961 Decadron method of use 53 2037-12-18

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10537585 Decadron formulation 25 2037-12-18
10159683 Decadron formulation 25 2034-05-23
10799642 Decadron formulation 31 2032-05-11
8409606 Decadron formulation 31 2030-05-14
8450287 Decadron formulation 38 2027-12-19
10022502 Decadron method of use 45 2034-06-22
10028965 Decadron method of use 45 2034-05-23
8563027 Decadron method of use 51 2030-02-12
11097061 Decadron method of use 53 2039-06-23
11304961 Decadron method of use 53 2037-12-18

Related